RCG
Ruane, Cunniff & Goldfarb’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $426M | Sell |
1,095,655
-27,265
| -2% | -$10.6M | 7.31% | 6 |
|
|
2025
Q1 | $488M | Sell |
1,122,920
-21,033
| -2% | -$9.15M | 8.87% | 3 |
|
|
2024
Q4 | $422M | Buy |
1,143,953
+139,420
| +14% | +$51.4M | 7.16% | 6 |
|
|
2024
Q3 | $522M | Sell |
1,004,533
-19,538
| -2% | -$10.2M | 8.17% | 3 |
|
|
2024
Q2 | $555M | Sell |
1,024,071
-50,614
| -5% | -$27.4M | 8.65% | 3 |
|
|
2024
Q1 | $557M | Sell |
1,074,685
-46,958
| -4% | -$24.3M | 8.65% | 3 |
|
|
2023
Q4 | $529M | Sell |
1,121,643
-28,578
| -2% | -$13.5M | 8.45% | 4 |
|
|
2023
Q3 | $501M | Buy |
1,150,221
+101,573
| +10% | +$44.2M | 8.31% | 3 |
|
|
2023
Q2 | $466M | Buy |
1,048,648
+241,524
| +30% | +$107M | 7.35% | 6 |
|
|
2023
Q1 | $371M | Sell |
807,124
-19,399
| -2% | -$8.92M | 6.06% | 7 |
|
|
2022
Q4 | $424M | Sell |
826,523
-161,334
| -16% | -$82.8M | 6.62% | 5 |
|
|
2022
Q3 | $449M | Sell |
987,857
-26,130
| -3% | -$11.9M | 6.67% | 5 |
|
|
2022
Q2 | $489M | Sell |
1,013,987
-743,441
| -42% | -$359M | 6.38% | 7 |
|
|
2022
Q1 | $863M | Sell |
1,757,428
-12,612
| -0.7% | -$6.2M | 8.5% | 2 |
|
|
2021
Q4 | $820M | Sell |
1,770,040
-51,373
| -3% | -$23.8M | 7.01% | 5 |
|
|
2021
Q3 | $679M | Sell |
1,821,413
-22,588
| -1% | -$8.42M | 6.1% | 6 |
|
|
2021
Q2 | $704M | Buy |
1,844,001
+672,156
| +57% | +$257M | 6.24% | 5 |
|
|
2021
Q1 | $421M | Buy |
+1,171,845
| New | +$421M | 3.96% | 15 |
|